Artrya Limited (AYA) Earnings Call Transcripts
Artrya Limited's Latest Earnings Call - Q4 FY2025
In the fourth quarter of 2025, Aya Gold & Silver Inc. reported record revenues of $75 million, significantly up from $34 million in Q1, driven by strong operational performance and increased silver prices. The company achieved a net income of $18 million, marking a substantial turnaround from a loss in the previous year. Management provided guidance for 2026, projecting silver production between 5.2 million and 5.8 million ounces, indicating confidence in operational stability and market conditions.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $202 million (beat) |
| Net Income | $46 million (beat) |
| Operating Cash Flow | $72 million (beat) |
| Earnings Per Share (EPS) | $0.32 (beat) |
| Milling Rate | 3,800 tonnes/day (positive) |
| Recovery Rate | 91.2% (positive) |
Guidance from management
Management expects to produce between 5.2 million and 5.8 million ounces of silver in 2026, with cash costs projected at $21.50 per ounce for Zgounder and $10 for Boumadine. This guidance reflects a conservative outlook based on the current mining plan.
What management said
Yes. Thanks, Justin. It's a very, very good question and very current question. We're on that on a regular basis, I'll turn this over to Ygo and ugo go and Rahael are managing that part you can imagine of the PEA. So Ugo, do you want to go ahead?
but Justin, Just in the PEA, the payability was established at 73%. Since then, they had revised their offer to 75% payability, and there's no long-term agreement yet signed because they're indicating to us that this will also improve as Ugo said considerably. So we're keeping all of the options open. We have an agreement that is signed for the Boumadine tailings because that is being exported every quarter right now...
What analysts pressed on
Analysts expressed concerns regarding potential bottlenecks in the fast-tracking of the Boumadine feasibility study and the impact of rising fuel prices on cash costs. There was also discussion about the company's disciplined approach to M&A opportunities in Morocco.
Main topics on the call
- Record Revenue and Profitability — Aya Gold & Silver achieved record revenues of $202 million for the full year 2025, with Q4 revenues reaching $75 million, a significant increase from $34 million in Q1. Management stated, "the fourth quarter was an excel...
- Strong Cash Flow and Balance Sheet — The company generated $72 million in operating cash flow for the year, compared to a negative $9 million in 2024. Aya ended the year with an unrestricted cash balance of $136 million, providing a solid foundation for fut...
- Production Guidance for 2026 — Management provided a conservative production guidance of 5.2 million to 5.8 million ounces for 2026, reflecting confidence in their operational capabilities. This guidance is based on the new mine plan at Zgounder, whic...
- Operational Improvements — The company reported a significant increase in milling rates, achieving an average of 3,800 tonnes per day in Q4, which is 40% above nameplate capacity. The recovery rate also improved to 91.2% in Q4, exceeding initial d...
Read the full Artrya Limited transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Artrya Limited
Artrya Limited (AYA) is a publicly listed company in the Health Care Technology industry, within the Health Care sector. It trades on ASX and is based in AU. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 11 calls on record spanning November 14, 2024 to July 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 11 Artrya Limited earnings call transcripts on record, spanning November 14, 2024 to July 30, 2026. Based on this history, Artrya Limited reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AYA
- Exchange
- ASX
- Country
- AU
- Sector
- Health Care
- Industry
- Health Care Technology
- Calls on record
- 11
- First call
- November 14, 2024
- Most recent
- July 30, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q4 FY2026 | Jul 30, 2026 | Read transcript → |
| Q1 FY2026 | May 14, 2026 | Read transcript → |
| Q3 FY2026 | May 1, 2026 | Read transcript → |
| Q4 FY2025 | Mar 31, 2026 | Read transcript → |
| Q1 FY2026 | Oct 29, 2025 | Read transcript → |
| Q3 FY2025 | May 1, 2025 | Read transcript → |
| Special Calls | Mar 31, 2025 | Read transcript → |
| Q4 FY2024 | Mar 28, 2025 | Read transcript → |
| Q2 FY2025 | Feb 3, 2025 | Read transcript → |
| Shareholder/Analyst Calls | Nov 28, 2024 | Read transcript → |
| Q3 FY2024 | Nov 14, 2024 | Read transcript → |